Strategy for the Prediction and Selection of Drug Substance Salt Forms - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Strategy for the Prediction and Selection of Drug Substance Salt Forms
Through consideration of the ionic equilibria of acids and bases, one may readily calculate the formation constant of a salt species solely on the basis of knowledge of the pKA value of the acid and the pKB value of the base.


Pharmaceutical Technology


Once formed, the conjugate base of an acidic substance (i.e., the anion of that acid) would also be capable of reacting with water:



Because aqueous solutions of anions are commonly prepared by the dissolution of a salt containing that anion, reactions of the type described by Equation 8 are often termed hydrolysis reactions. Equation 8 is necessarily characterized by a base ionization constant expression:



and a corresponding pK B defined in the usual manner.

However, because these ionic equilibria are taking place in aqueous media, the autoionization of water:



must also be considered. The equilibrium constant for this reaction would be:



In aqueous solutions, the concentration of water is effectively a constant (55.55 M), and so Equation 11 simplifies to:



K W is known as the autoionization constant of water and is sometimes identified as the ion product of water. The magnitude of K W is very small, being equal to 1.007 X 10–14 at a temperature of 25 °C (15). Substitution of Equation 12 into Equation 9 yields the relation:



However, the concentration terms in Equation 13 constitute the ionization constant expression for the conjugate acid of the conjugate base, providing the very useful relation regarding the relative strengths of conjugate acids and bases:



The same relation between ionization constants of a conjugate acid–base pair can be developed if one were to begin with the conjugate acid of a basic substance, so Equation 14 is recognized as a general property of conjugate acid–base pairs.

Ionic equilibria of salts

Salts are chemical compounds formed by the transfer of a proton from an acid (HA) to a base (B) capable of accepting that proton:


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here